<?xml version="1.0" encoding="UTF-8"?>
<p id="Par34">Concern about retroviruses led to the initiation of antibody testing for HTLV (1 and 2) in a number of countries and subsequently, the identification of HCV, the virus causing non-A, non-B hepatitis, led to the development of antibody tests for this infection. Subsequently, testing for antibodies to 
 <italic>Trypanosoma cruzi</italic>, the agent of Chagas disease, was implemented in the United States, although it has been in place for many years in South and Central America and parts of Mexico.
</p>
